Eli Lilly and Company

Eli Lilly and Company - ROEverified

LLY.SW

Price:

$955

Market Cap:

$1.09T

Eli Lilly and Company is a global pharmaceutical enterprise engaged in the discovery, development, and commercialization of human pharmaceutical products. Its diverse portfolio provides treatments across multiple therapeutic areas. In the field of diabetes care, the company offers a comprehensive range of insulins, such as Basaglar, various formulations of Humalog (including U-100, U-200, Mix 75/25, and Mix 50/50), insulin lispro, insulin lispro protamine, and insulin lispro mix 75/25. Additionally, its Humulin line features Humulin 70/30, Humulin N, Humulin R, and Humulin U-500. For the management of type 2 diabetes, key medications include Jardiance, Trajenta, and Trulicity. Its oncology d...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1998-07-17

Stock Exchange

SIX

Ticker

LLY.SW

The ROE as of September 2026 (TTM) for Eli Lilly and Company (LLY.SW) is 92.58%

According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current ROE is 92.58%. This represents a change of 297.66% compared to the average of 23.28% of the last 4 quarters.

Eli Lilly and Company (LLY.SW) Historical ROE (quarterly & annually)

How has LLY.SW ROE performed in the past?

The mean historical ROE of Eli Lilly and Company over the last ten years is 80.14%. The current 92.58% ROE has changed 15.53% with respect to the historical average. Over the past ten years (40 quarters), LLY.SW's ROE was at its highest in in the March 2019 quarter at 171.01%. The ROE was at its lowest in in the December 2017 quarter at -14.29%.

Quarterly (TTM)
Annual

Average

80.14%

Median

60.40%

Minimum

-1.76%

Maximum

319.09%

Eli Lilly and Company (LLY.SW) ROE by Quarter and Year

Discovering the peaks and valleys of Eli Lilly and Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 870.38%

Maximum Annual ROE = 319.09%

Minimum Annual Increase = -1967.66%

Minimum Annual ROE = -1.76%

Quarterly (TTM)
Annual
YearROEChange
202577.78%4.24%
202474.62%53.38%
202348.65%-17.03%
202258.64%-5.67%
202162.16%-43.38%
2020109.79%-65.59%
2019319.09%870.38%
201832.88%-1967.66%
2017-1.76%-109.01%
201619.54%18.24%

Eli Lilly and Company (LLY.SW) Average ROE

How has LLY.SW ROE performed in the past?

The current ROE of Eli Lilly and Company (LLY.SW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

67.02%

5-year avg

64.37%

10-year avg

80.14%

Eli Lilly and Company (LLY.SW) ROE vs. Peers

How is LLY.SW’s ROE compared to its peers?

Eli Lilly and Company’s ROE is less than Roche Holding AG (37.12%), less than Novartis AG (29.64%), greater than Cosmo Pharmaceuticals N.V. (-1.21%), less than Abbott Laboratories (10.52%), greater than Lonza Group AG (-1.28%), less than Ypsomed Holding AG (28.54%), less than Siegfried Holding AG (16.14%), less than Ascom Holding AG (24.40%), less than Alcon Inc. (2.91%),

Build a custom stock screener for Eli Lilly and Company (LLY.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eli Lilly and Company (LLY.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Eli Lilly and Company's ROE?

How is the ROE calculated for Eli Lilly and Company (LLY.SW)?

What is the highest ROE for Eli Lilly and Company (LLY.SW)?

What is the 3-year average ROE for Eli Lilly and Company (LLY.SW)?

What is the 5-year average ROE for Eli Lilly and Company (LLY.SW)?

How does the current ROE for Eli Lilly and Company (LLY.SW) compare to its historical average?